Brazil Prothrombin Complex Concentrate (PCC) Market Outlook

brazil is one of the leading countries in terms of demand of prothrombin complex concentrate (pcc). this is primarily due to the growing elderly population in the country, increasing incidence of bleeding disorders and enhanced access to quality healthcare in brazil. pcc is used as a substitute coagulation factors for a variety of bleeding disorders including protein c deficiency, warfarin-related overdose and hemophilia a with inhibitors. according to a world health organization report, an estimated 1.2 million people in brazil suffer from hemophilia a. hemophilia b, on the other hand, affects 0.3 million individuals in the country. these figures are likely to significantly impact the demand for prothrombin complex concentrate in brazil in coming years. the government of brazil has taken various initiatives to improve the healthcare infrastructure in the country, which are likely to enable further access to quality healthcare. moreover, educational programs about inherited bleeding disorders are organized in the country to increase the understanding of pcc from the perspective of treatment and management. such initiatives are expected to drive the awareness of the product and further drive its demand. brazil is home to several leading generic manufacturers that manufacture pcc for the local and export markets. these companies are focused on introducing new and cost-effective formulations of the product. this, in turn, is expected to further bolster the demand of prothrombin complex concentrate in the country in the years to come. the increasing elderly population and growing awareness about inherited bleeding disorder further coupled with the development of healthcare infrastructure in the country, are likely to drive the demand for prothrombin complex concentrate market in brazil over the forecast period.